Skip to main content
Sinopharm Tech Holdings Limited logo

Sinopharm Tech Holdings Limited — Investor Relations & Filings

Ticker · 8156 ISIN · KYG2159V1418 HKEX Wholesale and retail trade
Open in API
Filings indexed 1,471 across all filing types
Latest filing 2021-06-30 Report Publication Anno…
Country HK Hong Kong
Listing HKEX 8156

About Sinopharm Tech Holdings Limited

http://www.sinopharmtech.com.hk

Sinopharm Tech Holdings Limited is an investment holding company primarily engaged in the big health industry and pharmaceutical supply chain business. The company focuses on the trading and distribution of medical and related products, including Chinese patent medicines and health products, targeting the market in the PRC. It develops its supply chain operations using "Internet Plus" services, leveraging technology to provide value-added services to industry operators and product suppliers. The Group is also integrating AI analytics to enhance its operations within the healthcare sector.

Recent filings

Filing Released Lang Actions
DELAY IN DESPATCH OF CIRCULAR
Report Publication Announcement Classification · 95% confidence The document is an announcement from Sinopharm Tech Holdings Limited regarding a delay in the despatch of a circular related to connected transactions involving loan capitalisation and issuance of new shares. It references previous announcements and states that the circular, which includes detailed information and notices for an Extraordinary General Meeting (EGM), will be delayed. The document is short (3406 characters) and serves as an update or notice about the timing of a report (the circular), rather than containing the circular itself or substantive financial data. Therefore, it fits the criteria of a Report Publication Announcement (RPA) rather than the actual report or financial filing.
2021-06-30 English
SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO (1) CONNECTED TRANSACTIONS: LOAN CAPITALISATION INVOLVING ISSUE OF NEW SHARES UNDER GENERAL MANDATE&#x3b; AND (2) LOAN CAPITALISATION INVOLVING ISSUE OF NEW SH
Capital/Financing Update Classification · 95% confidence The document is an announcement from Sinopharm Tech Holdings Limited regarding supplemental information related to connected transactions involving loan capitalisation and the issue of new shares under a general mandate. It references a previous announcement dated 8 June 2021 and provides additional details about the independence of certain agreements and voting requirements at an Extraordinary General Meeting (EGM). The content focuses on shareholding details, voting abstentions, and clarifications about the transactions. There are no financial statements, earnings data, or detailed financial analysis present. The document is not a full financial report but rather an update or supplemental announcement related to capital transactions and shareholder voting matters. This fits the category of Capital/Financing Update (CAP) as it deals with financing activities and capital structure changes through loan capitalisation and share issuance under a general mandate.
2021-06-24 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Board/Management Information Classification · 95% confidence The document lists the members of the board of directors and their roles, including executive, non-executive, and independent non-executive directors, as well as the composition of board committees (Audit, Remuneration, Nomination). There is no financial data, no report or announcement of financial results, no voting results, no legal proceedings, no capital changes, and no mention of any meeting or shareholder vote. The content is focused solely on board and management composition and committee roles. This matches the definition of Board/Management Information (MANG), which covers announcements of changes or details about the company's board of directors or senior management. The document length is short (1165 characters), and it is not an announcement of a report publication or a certification. Therefore, the correct classification is MANG with high confidence.
2021-06-17 English
RESIGNATION OF NON-EXECUTIVE DIRECTOR AND APPOINTMENT OF EXECUTIVE DIRECTORS AND CHIEF OPERATING OFFICER
Board/Management Information Classification · 100% confidence The document is an announcement from Sinopharm Tech Holdings Limited regarding the resignation of a non-executive director and the appointment of two executive directors and a chief operating officer. It details the individuals' backgrounds, roles, and remuneration. There is no financial data, earnings information, or report attached or referenced as being published. The content focuses solely on changes in the company's board and senior management. Therefore, this fits the category of Board/Management Information (MANG). The document length and detail support this classification with high confidence.
2021-06-17 English
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 9 JUNE 2021
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an announcement of the poll results from an Extraordinary General Meeting (EGM) held on 9 June 2021. It details the voting outcomes on resolutions related to the adoption and termination of share option schemes. The text explicitly states it is announcing the poll results and does not contain full meeting materials or detailed reports. The document length is 3990 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2021-06-09 English
(1) CONNECTED TRANSACTIONS: LOAN CAPITALISATION INVOLVING ISSUE OF NEW SHARES UNDER GENERAL MANDATE&#x3b; AND (2) LOAN CAPITALISATION INVOLVING ISSUE OF NEW SHARES UNDER GENERAL MANDATE
Capital/Financing Update Classification · 95% confidence The document is an announcement from Sinopharm Tech Holdings Limited regarding loan capitalisation transactions involving the issue of new shares under a general mandate. It details agreements entered into on 8 June 2021 with connected persons and independent third parties to convert loans into shares. The announcement includes specifics about the number of shares, subscription prices, conditions precedent, and regulatory implications under the GEM Listing Rules. It is a detailed disclosure about financing activities related to share issuance and loan capitalisation, not a full financial report or earnings release. The document is lengthy (15,000 characters) and contains substantive information about capital structure changes and connected transactions. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2021-06-09 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.